Filters
Canagliflozin
Canagliflozin is a highly selective inhibitor of the sodium-glucose inhibition with canagliflozin increases glucose excretion by the kidneys, resulting. Canagliflozin is currently approved for the treatment of type 2 diabet...
FB - Endokrinologie, diabetologie, metabolismus, výživa
- 2014 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Canagliflozin
Canagliflozin is an oral antidiabetic drug from the classof sodium-glucose of canagliflozin in monotherapyor in combination with other antidiabetics in patients a beneficial effectof canagliflozin on the incidence of major ...
Endocrinology and metabolism (including diabetes, hormones)
- 2023 •
- Jost •
- Link
Rok uplatnění
Jost - Ostatní články v recenzovaných periodicích
Výsledek na webu
Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes
Aims: To assess the efficacy and safety of canagliflozin, a sodium glucose co in the CANagliflozin cardioVascular Assessment Study (CANVAS) who were on an incretin mimetic participants to canagliflozin 100 or 300 mg or plac...
FB - Endokrinologie, diabetologie, metabolismus, výživa
- 2016 •
- Jx •
- Link
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Výsledek na webu
Canagliflozin and its position in the treatment of type 2 diabetes
Canagliflozin is an inhibitor of sodium-glucose cotransporter 2 (SGLT2 inhibitors, dose titration from 100 mg to 300 mg is possible with canagliflozin the mechanism of action of canagliflozin and its pharmacokinetics and dr...
Endocrinology and metabolism (including diabetes, hormones)
- 2024 •
- Jost •
- Link
Rok uplatnění
Jost - Ostatní články v recenzovaných periodicích
Výsledek na webu
Canagliflozin: clinical significance of simultaneous balanced influencing of SGLT2 and SGLT1
Gliflozins - or SGLT2 inhibitors - interfere with renal glucose reabsorption by inhibiting glucose transporters SGLT2. As a result, they cause glucosuria, glycemia lowering, loss of energy with weight reduction, and improvement of diabetes compensati...
FB - Endokrinologie, diabetologie, metabolismus, výživa
- 2015 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Fixed dose combination of canagliflozin and metformin
The fixed-dose combination canagliflozin/metformin is indicated in patients with type 2 diabetes as adjuvant therapy together with diet and exercise regimen, provided the disease cannot be controlled with monotherapy. Canagliflozin,...
FB - Endokrinologie, diabetologie, metabolismus, výživa
- 2015 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CANVAS – Canagliflozin and cardiovascular or renal influence for diabetes mellitus type 2
Canagliflozin is a sodium-glucose cotransporter 2 inhibitor that reduces glycaemia as well as blood pressure, body weight, and albuminuria in people in each trial were randomly assigned to receive canagliflozin or placebo and were o...
General and internal medicine
- 2019 •
- JSC •
- Link
Rok uplatnění
JSC - Článek v periodiku v databázi SCOPUS
Výsledek na webu
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
BACKGROUND Canagliflozin is a sodium-glucose cotransporter 2 inhibitor with diabetes. We report the effects of treatment with canagliflozin on cardiovascular canagliflozin or placebo and were followed for a mean of 188.2 we...
Endocrinology and metabolism (including diabetes, hormones)
- 2017 •
- Jimp •
- Link
Rok uplatnění
Jimp - Článek v periodiku v databázi Web of Science
Výsledek na webu
Alternative method for canagliflozin oxidation analysis using an electrochemical flow cell - Comparative study
-stress testing of active pharmaceutical ingredients using canagliflozin as a model of canagliflozin, and the percentage of the corresponding peak areas. Our results showed of canagliflozin, namely 50 µm cell size, 300 mM e...
Analytical chemistry
- 2022 •
- Jimp •
- Link
Rok uplatnění
Jimp - Článek v periodiku v databázi Web of Science
Výsledek na webu
Canagliflozin-loaded magnetic nanoparticles as potential treatment of hypoxic tumors in combination with radiotherapy
Aim: To synthesize magnetic nanoparticles loaded with the SGLT2-inhibitor canagliflozin (CANA) and evaluate its anticancer potential under normoxic and hypoxic conditions in combination or not with radiotherapy. Material & methods: Iron ...
Physical chemistry
- 2018 •
- Jimp •
- Link
Rok uplatnění
Jimp - Článek v periodiku v databázi Web of Science
Výsledek na webu
- 1 - 10 out of 24